Decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin is as effective as standard dose chemotherapy in the induction treatment for patients aged from 55 to 69 years old with newly diagnosed acute myeloid leukemia-Reference-Cited by-同舟云学术

Decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin is as effective as standard dose chemotherapy in the induction treatment for patients aged from 55 to 69 years old with newly diagnosed acute myeloid leukemia

Published:2018-04-04 Issue:11 Volume:59 Page:2570-2579
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Huang Jiayu¹,Hong Ming¹,Zhu Yu¹,Zhao Huihui¹²,Zhang Xiaoyan¹,Wu Yujie¹,Lian Yun¹,Zhao Xiaoli¹,Li Jianyong¹,Qian Sixuan¹

Affiliation:

1. Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Key Laboratory of Hematology, Nanjing Medical University, Nanjing, China;

2. Department of Oncology, The Second Affiliated Hospital of Southeast University, Nanjing, China

Funder

National Natural Science Foundation of the People’s Republic of China

National Public Health Grand Research Foundation

A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institute

Key Project of Jiangsu Province Health Agency

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1443328